NMRA
Price
$1.41
Change
-$0.05 (-3.45%)
Updated
Jul 16, 04:59 PM (EDT)
Capitalization
234.53M
27 days until earnings call
REG
Price
$69.43
Change
+$0.81 (+1.18%)
Updated
Jul 16 closing price
Capitalization
11.19B
12 days until earnings call
Interact to see
Advertisement

NMRA vs REG

Header iconNMRA vs REG Comparison
Open Charts NMRA vs REGBanner chart's image
Neumora Therapeutics
Price$1.41
Change-$0.05 (-3.45%)
Volume$8.64K
Capitalization234.53M
Regency Centers
Price$69.43
Change+$0.81 (+1.18%)
Volume$1.02M
Capitalization11.19B
NMRA vs REG Comparison Chart in %
Loading...
NMRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
REG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NMRA vs. REG commentary
Jul 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NMRA is a StrongBuy and REG is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 17, 2025
Stock price -- (NMRA: $1.40 vs. REG: $69.43)
Brand notoriety: NMRA and REG are both not notable
NMRA represents the Biotechnology, while REG is part of the Real Estate Investment Trusts industry
Current volume relative to the 65-day Moving Average: NMRA: 119% vs. REG: 91%
Market capitalization -- NMRA: $226.45M vs. REG: $11.19B
NMRA [@Biotechnology] is valued at $226.45M. REG’s [@Real Estate Investment Trusts] market capitalization is $11.19B. The market cap for tickers in the [@Biotechnology] industry ranges from $300.78B to $0. The market cap for tickers in the [@Real Estate Investment Trusts] industry ranges from $243.79B to $0. The average market capitalization across the [@Biotechnology] industry is $2.44B. The average market capitalization across the [@Real Estate Investment Trusts] industry is $5.44B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NMRA’s FA Score shows that 1 FA rating(s) are green whileREG’s FA Score has 1 green FA rating(s).

  • NMRA’s FA Score: 1 green, 4 red.
  • REG’s FA Score: 1 green, 4 red.
According to our system of comparison, REG is a better buy in the long-term than NMRA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NMRA’s TA Score shows that 5 TA indicator(s) are bullish while REG’s TA Score has 3 bullish TA indicator(s).

  • NMRA’s TA Score: 5 bullish, 4 bearish.
  • REG’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, NMRA is a better buy in the short-term than REG.

Price Growth

NMRA (@Biotechnology) experienced а +37.25% price change this week, while REG (@Real Estate Investment Trusts) price change was +0.59% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.56%. For the same industry, the average monthly price growth was +10.24%, and the average quarterly price growth was +39.21%.

The average weekly price growth across all stocks in the @Real Estate Investment Trusts industry was +0.43%. For the same industry, the average monthly price growth was +3.02%, and the average quarterly price growth was +3.53%.

Reported Earning Dates

NMRA is expected to report earnings on Aug 12, 2025.

REG is expected to report earnings on Oct 28, 2025.

Industries' Descriptions

@Biotechnology (+2.56% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

@Real Estate Investment Trusts (+0.43% weekly)

A real estate investment trust (REIT) is a company any that owns, and in most cases, operates, income-producing real estate – ranging from office and apartment buildings to warehouses, hospitals, shopping centers, hotels and timberlands. Some REITs are involved in financing real estate. Equity REITs invest in and own properties, while mortgage REITs own and invest in property mortgages. REITs are required by law to pay out at least 90% of their annual taxable income (excluding capital gains) to shareholders in the form of dividends. Some REITs could be more cyclical than others; for example, when an economy is undergoing a recession, hotel REITs could be more vulnerable, compared to say healthcare REIT given that healthcare needs are less likely to depend on economic cycles. American Tower Corporation, Prologis, Inc. and Crown Castle International Corp are some of the biggest REIT companies in the U.S.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
REG($11.2B) has a higher market cap than NMRA($235M). REG YTD gains are higher at: -4.251 vs. NMRA (-86.321). REG has higher annual earnings (EBITDA): 879M vs. NMRA (-273.7M). NMRA has more cash in the bank: 249M vs. REG (85M). NMRA has less debt than REG: NMRA (938K) vs REG (4.4B). REG has higher revenues than NMRA: REG (1.32B) vs NMRA (0).
NMRAREGNMRA / REG
Capitalization235M11.2B2%
EBITDA-273.7M879M-31%
Gain YTD-86.321-4.2512,031%
P/E RatioN/A29.24-
Revenue01.32B-
Total Cash249M85M293%
Total Debt938K4.4B0%
FUNDAMENTALS RATINGS
REG: Fundamental Ratings
REG
OUTLOOK RATING
1..100
70
VALUATION
overvalued / fair valued / undervalued
1..100
76
Overvalued
PROFIT vs RISK RATING
1..100
27
SMR RATING
1..100
82
PRICE GROWTH RATING
1..100
58
P/E GROWTH RATING
1..100
43
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NMRAREG
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 1 day ago
58%
Momentum
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 1 day ago
50%
MACD
ODDS (%)
Bullish Trend 2 days ago
89%
Bearish Trend 1 day ago
50%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 1 day ago
59%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 1 day ago
50%
Advances
ODDS (%)
Bullish Trend 6 days ago
87%
Bullish Trend 3 days ago
56%
Declines
ODDS (%)
Bearish Trend 17 days ago
85%
Bearish Trend 8 days ago
49%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 1 day ago
71%
Aroon
ODDS (%)
Bullish Trend 2 days ago
87%
Bearish Trend 1 day ago
32%
View a ticker or compare two or three
Interact to see
Advertisement
NMRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
REG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
FOREX / NAMEPrice $Chg $Chg %
USDCAD1.370.00
+0.09%
United States Dollar - Canadian Dollar
SHRAX106.26N/A
N/A
ClearBridge Growth A
GSRRX11.38N/A
N/A
Goldman Sachs Rising Dividend Gr R
MFWLX17.22N/A
N/A
MFS Global Total Return R6
CBGAX14.27N/A
N/A
ClearBridge Global Infrastructure Inc C